October 2017 IBC Meeting Minutes
National Biosafety Month 2017: Sharps Safety and Exposure Response
October 26, 2017
During 2017's National Biosafety Month, you are encouraged to focus attention on biosafety policies, practices and procedures. Investigators and laboratory managers should raise biosafety awareness, discuss the importance of safety, and seek input on ways to strengthen biosafety practices and procedures in their labs. This year, EH&S is focusing on sharps safety in research and exposure response.
Disaster Response (PEAT)
The Pre-Entry Assessment Team (PEAT) is the UW's first responder disaster team that consists of members of EH&S and UW Tacoma Safety and Security.
Chemotherapy and Other Hazardous Drugs: Safe Use Guidelines
Lab Safety Checklist Explanations
Shipping a Biological Substance, Category B using IATA packing instruction 6502
Chemotherapy & Hazardous Drugs
Drugs are classified as hazardous if they may cause cancer, developmental or reproductive toxicity or harm to organs at low doses. They include drugs used for cancer chemotherapy (also called antineoplastics), antiviral drugs, hormones, some bioengineered drugs and other various drugs.
Check the NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 to determine if a drug is classified as hazardous.
Clinical Trials
Any research involving the administration of infectious agents or recombinant or synthetic nucleic acids to human research participants requires review and approval by the UW Institutional Biosafety Committee (IBC) if it is sponsored by or conducted at the University of Washington. Infectious agents are biological organisms capable of causing disease in humans, generally Risk Group 2 or higher.